A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2004
12/08/2004	EP1483232A1 Salts of nateglinide
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	EP1483023A1 Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482976A1 A preparation and method for weight reduction
12/08/2004	EP1482968A2 Treatment of type i diabetes mellitus using growth hormone antagonist
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482954A2 Alpha-substituted arylalkyl phosphonate derivatives
12/08/2004	EP1482953A1 Alpha-substituted heteroarylalkyl phosphonate derivattives
12/08/2004	EP1482951A1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
12/08/2004	EP1482950A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482935A1 Thiazole and oxazole derivatives which modulate ppar activity
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482929A1 Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1482920A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
12/08/2004	EP1482919A1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482811A1 Probiotic delivery system
12/08/2004	EP1482787A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
12/08/2004	EP1444345A4 Conversion of liver stem and progenitor cells to pancreatic functional cells
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1220669A4 Therapeutic intervention to mimic the effect of caloric restriction
12/08/2004	EP1168934A4 Hydrogel-forming system with hydrophobic and hydrophilic components
12/08/2004	EP1157013B1 Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments
12/08/2004	EP1141014B1 Insulin-like growth factor (igf) i mutant variant
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP1114040B1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
12/08/2004	CN1553805A Nutritional compositions for controlling blood glucose level
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553799A Dosage forms having prolonged active ingredient release
12/08/2004	CN1553798A Modifying the fatty acid composition of cell membranes of organs and tissues
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552431A Chinese medicinal preparation for lowering viscosity and preventing embolism
12/08/2004	CN1552353A Composition for treating diabets mellitus and preparing method thereof
12/08/2004	CN1552341A Medicine for preventing diabets mellitus
12/08/2004	CN1552315A 治疗组合物 The therapeutic composition
12/08/2004	CN1552311A Oral dissolved fenofibrate tablets
12/08/2004	CN1552252A Producing method for alginic biological nutrient iodine size
12/08/2004	CN1552227A Tea
12/08/2004	CN1179037C Bacillus substilis Var. chungkookjang producing high molecular weight poly-gamma-glutamic acid
12/08/2004	CN1179026C Fat compositions
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178954C Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/08/2004	CN1178950C Corpuscles of stannius protein and stanniocalcin
12/08/2004	CN1178946C Vanadium compound and its preparing process and usage
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178901C New-cyclic alpha-amino-gamma hydroxy amide compound and its preparing method and medicinal composition containing said compound
12/08/2004	CN1178889C Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
12/08/2004	CN1178696C Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor
12/08/2004	CN1178684C Medicine for treating blood fat abnormal and its preparation method
12/08/2004	CN1178678C Process for preparing arnebia root medicine with broad-spectrum medical functions
12/08/2004	CN1178676C Fructo-iodine and its preparing process
12/08/2004	CN1178666C Gypenoside drip pill, and preparing process thereof
12/07/2004	US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004	US6828440 Analgesics; side effect reduction
12/07/2004	US6828424 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent
12/07/2004	US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828332 Piperidine derivatives as reuptake inhibitors
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828324 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6828314 Modulation of the activity of serotonin receptors (5-HT) to treat diseases such as anxiety, depression or obesity
12/07/2004	US6828306 Charged lipid compositions and methods for their use
12/07/2004	US6828297 For therapy of diabetes
12/07/2004	CA2316921C Aryl fused azapolycyclic compounds
12/07/2004	CA2112331C Novel naphthalene derivatives
12/07/2004	CA2108817C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
12/02/2004	WO2004104575A2 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2)
12/02/2004	WO2004104036A1 Process for producing soyeban whey protein and digested soybean whey protein
12/02/2004	WO2004104009A1 Process for making spirolactone compounds
12/02/2004	WO2004103997A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS PPAR-α ACTIVATORS
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103988A1 Sulfur-containing proanthocyanidin oligomer composition and process for producing the same
12/02/2004	WO2004103980A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
12/02/2004	WO2004103954A1 Amide derivative
12/02/2004	WO2004103946A1 Carboxylic acid compound and medicine containing the same
12/02/2004	WO2004103403A1 Immunocompetent cell activation inhibitor and use thereof
12/02/2004	WO2004103383A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein
12/02/2004	WO2004103375A1 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1
12/02/2004	WO2004103370A1 Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions
12/02/2004	WO2004103276A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

1 ... 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 ... 1298